Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

Walsh, M. J.; Jonsson, J. R.; Richardson, M. M.; Lipka, G. M.; Purdie, D. M.; Clouston, A. D.; Powell, E. E.
April 2006
Gut;Apr2006, Vol. 55 Issue 4, p529
Academic Journal
Background: Interferon α (IFN-α) activated cellular signalling is negatively regulated by inhibitory factors, including the suppressor of cytokine signalling (SOCS) family. The effects of host factors such as obesity on hepatic expression of these inhibitory factors in subjects with chronic hepatitis C virus (HCV) are unknown. Objectives: To assess the independent effects of obesity, insulin resistance, and steatosis on response to IFN-α therapy and to determine hepatic expression of factors inhibiting IFN-α signalling in obese and non-obese subjects with chronic HCV. Methods: A total of 145 subjects were analysed to determine host factors associated with non-response to antiviral therapy. Treatment comprised IFN-α or peginterferon alpha, either alone or in combination with ribavirin. In a separate cohort of 73 patients, real time-polymerase chain reaction was performed to analyse hepatic mRNA expression. Immunohistochemistry for SOCS-3 was performed on liver biopsy samples from 38 patients with viral genotype 1 who had received antiviral treatment. Results: Non-response (NR) to treatment occurred in 55% of patients with HCV genotypes 1 or 4 and 22% with genotypes 2 or 3. Factors independently associated with NR were viral genotype 1/4 (p<0.001), cirrhosis on pretreatment biopsy (p = 0.025), and body mass index ≥ 30 kg/m² (p = 0.010). Obese subjects with viral genotype 1 had increased hepatic mRNA expression of phosphoenolpyruvate carboxy kinase (p = 0.01) and SOCS-3 (p = 0.047), in comparison with lean subjects. Following multivariate analysis, SOCS-3 mRNA expression remained independently associated with obesity (p = 0.023). SOCS-3 immunoreactivity was significantly increased in obesity (p = 0.013) and in non-responders compared with responders (p = 0.014). Conclusions: In patients with chronic HCV viral genotype 1, increased expression of factors that inhibit interferon signaling may be one mechanism by which obesity reduces the biological response to IFN-α.


Related Articles

  • Mechanisms Linking Inflammation to Insulin Resistance. Chen, Li; Chen, Rui; Wang, Hua; Liang, Fengxia // International Journal of Endocrinology;6/2/2015, Vol. 2015, p1 

    Obesity is now widespread around the world. Obesity-associated chronic low-grade inflammation is responsible for the decrease of insulin sensitivity, which makes obesity a major risk factor for insulin resistance and related diseases such as type 2 diabetes mellitus and metabolic syndromes. The...

  • PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation. Lupberger, Joachim; Casanova, Claudia; Fischer, Benoit; Weiss, Amelie; Fofana, Isabel; Fontaine, Nelly; Fujiwara, Toshinobu; Renaud, Mickael; Kopp, Arnaud; Schuster, Catherine; Brino, Laurent; Baumert, Thomas F.; Thoma, Christian // Scientific Reports;9/4/2015, p13344 

    Cellular translation is down-regulated by host antiviral responses. Picornaviridae and Flaviviridae including hepatitis C virus (HCV) evade this process using internal ribosomal entry sequences (IRESs). Although HCV IRES translation is a prerequisite for HCV replication, only few host factors...

  • Effects of physical exercise in molecular parameters of the route of obesity and insulin signaling. de Farias, Joni Marcio // Brazilian Journal of Kineanthropometry & Human Performance;2014, Vol. 16 Issue 5, p588 

    The prevalence of obesity and diabetes mellitus has increased significantly in recent years and the knowledge that adipose tissue has endocrine activity and plays important roles in regulating inflammation and energy metabolism by molecular mechanisms among others is a source of new studies....

  • Antiviral Interferon-Beta Signaling Induced by Designed Transcription Activator-Like Effectors (TALE). Renner, Ivonne; Funk, Nancy; Geissler, Rene; Friedrich, Susann; Penzel, Anika; Behrens, Sven-Erik // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Here we show that designed transcription activator-like effectors (TALEs) that bind to defined areas of the interferon beta promoter are capable to induce IFN-beta expression and signaling in human cells. Importantly, TALE-mediated IFN-beta signaling occurs independently of pathogen pattern...

  • Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes. Friborg, Jacques; Ross-Macdonald, Petra; Cao, Jian; Willard, Ryan; Lin, Baiqing; Eggers, Betsy; McPhee, Fiona // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Peginterferon lambda-1a (Lambda), a type III interferon (IFN), acts through a unique receptor complex with limited cellular expression outside the liver which may result in a differentiated tolerability profile compared to peginterferon alfa (alfa). In Phase 2b clinical studies, Lambda...

  • In vitro Evidence for Association Between Hepatitis C Virus Infection and Insulin Signaling Pathways: A Review. Khedmat, Hossein; Agah, Shahram; Taheri, Saeed // Pakistan Journal of Biological Sciences;2014, Vol. 17 Issue 5, p601 

    Hepatitis C virus infection, besides its substantial unfavorable impact on liver health, has several other manifestations, from which we have focused on its associations with insulin resistance and diabetes mellitus in an in vitro setting in this review of the literature. Several epidemiologic...

  • Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Ting-ting Gao; Zhao-ling Qin; Hao Ren; Ping Zhao; Zhong-tian Qi // Virology Journal;2015, Vol. 12 Issue 1, p1 

    Background: Hepatitis C virus (HCV) infection was recently recognized as an independent risk factor for insulin resistance (IR), the onset phase of type 2 diabetes mellitus (T2DM). Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) negatively regulates PI3K/Akt signaling pathway,...

  • Targeted therapy for renal cell carcinoma: a new treatment paradigm. Hutson, Thomas E. // Baylor University Medical Center Proceedings;Jul2007, Vol. 20 Issue 3, p244 

    Metastatic clear cell renal cell cancer has traditionally been treated with cytokines (interferon or interleukin-2). Improved understanding of biology has engendered novel targeted therapeutic agents that have altered the natural history of this disease. The vascular endothelial growth factor...

  • The GTPase Rab37 Participates in the Control of Insulin Exocytosis. Ljubicic, Sanda; Bezzi, Paola; Brajkovic, Saska; Nesca, Valeria; Guay, Claudiane; Ohbayashi, Norihiko; Fukuda, Mitsunori; Abderrhamani, Amar; Regazzi, Romano // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Rab37 belongs to a subclass of Rab GTPases regulating exocytosis, including also Rab3a and Rab27a. Proteomic studies indicate that Rab37 is associated with insulin-containing large dense core granules of pancreatic β-cells. In agreement with these observations, we detected Rab37 in extracts...


Read the Article


Sign out of this library

Other Topics